Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of NANO MRNA Co., Ltd.. A complete text table follows the diagram.
Only JPY41 million of sales supported a JPY214 million R&D program spanning mRNA, DDS and regenerative medicine.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Technology materials and marketed products | 1 | 41.1M | 100.0% of reported total |
| Net Sales | 2 | 41.1M | Reported six-month total · ¥41M |
| Operating loss | 2 | 399M | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 440M | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Technology materials and marketed products | Net Sales | 41.1M |
| Net Sales | Operating costs & expenses | 41.1M |
| Operating loss | Operating costs & expenses | 399M |